

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | uronic acid metabolic process (GO:0006063) | 9.72999317 |
| 2 | glucuronate metabolic process (GO:0019585) | 9.72999317 |
| 3 | cellular glucuronidation (GO:0052695) | 9.68290848 |
| 4 | glutathione derivative biosynthetic process (GO:1901687) | 5.84093093 |
| 5 | glutathione derivative metabolic process (GO:1901685) | 5.84093093 |
| 6 | benzene-containing compound metabolic process (GO:0042537) | 5.74741777 |
| 7 | receptor recycling (GO:0001881) | 5.64843601 |
| 8 | regulation of cholesterol esterification (GO:0010872) | 5.52507621 |
| 9 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.51867572 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.43200926 |
| 11 | cardiac right ventricle morphogenesis (GO:0003215) | 5.42442885 |
| 12 | one-carbon compound transport (GO:0019755) | 5.34875596 |
| 13 | renal absorption (GO:0070293) | 5.33301345 |
| 14 | regulation of cholesterol biosynthetic process (GO:0045540) | 5.10676581 |
| 15 | glutathione metabolic process (GO:0006749) | 4.94050808 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.92673252 |
| 17 | cardiac epithelial to mesenchymal transition (GO:0060317) | 4.59530963 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.48433021 |
| 19 | keratinocyte development (GO:0003334) | 4.46770041 |
| 20 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 4.39206713 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 4.37104858 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.37104858 |
| 23 | mesenchymal cell proliferation (GO:0010463) | 4.37030964 |
| 24 | phospholipid efflux (GO:0033700) | 4.33666673 |
| 25 | doxorubicin metabolic process (GO:0044598) | 4.33558368 |
| 26 | daunorubicin metabolic process (GO:0044597) | 4.33558368 |
| 27 | polyketide metabolic process (GO:0030638) | 4.33558368 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.30550229 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 4.27576446 |
| 30 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.22537397 |
| 31 | low-density lipoprotein particle remodeling (GO:0034374) | 4.22404020 |
| 32 | L-ascorbic acid metabolic process (GO:0019852) | 4.14802668 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 4.13926213 |
| 34 | hormone catabolic process (GO:0042447) | 4.12353580 |
| 35 | limb bud formation (GO:0060174) | 4.10997600 |
| 36 | phospholipid homeostasis (GO:0055091) | 4.07752150 |
| 37 | regulation of superoxide anion generation (GO:0032928) | 4.07294779 |
| 38 | positive regulation of steroid biosynthetic process (GO:0010893) | 4.04507986 |
| 39 | cartilage morphogenesis (GO:0060536) | 4.00900604 |
| 40 | protein localization to cilium (GO:0061512) | 4.00616169 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.99712487 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 3.99712487 |
| 43 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.99330287 |
| 44 | gland morphogenesis (GO:0022612) | 3.98854674 |
| 45 | interferon-gamma secretion (GO:0072643) | 3.96695634 |
| 46 | positive regulation of steroid metabolic process (GO:0045940) | 3.94921638 |
| 47 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.92015667 |
| 48 | thrombin receptor signaling pathway (GO:0070493) | 3.91756730 |
| 49 | negative regulation of lipase activity (GO:0060192) | 3.91640183 |
| 50 | cGMP metabolic process (GO:0046068) | 3.88559435 |
| 51 | lung lobe morphogenesis (GO:0060463) | 3.85678280 |
| 52 | regulation of chemokine secretion (GO:0090196) | 3.80928021 |
| 53 | polyol transport (GO:0015791) | 3.74497984 |
| 54 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.74482837 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.69664232 |
| 56 | cGMP biosynthetic process (GO:0006182) | 3.69473268 |
| 57 | cellular response to nicotine (GO:0071316) | 3.68010591 |
| 58 | sequestering of actin monomers (GO:0042989) | 3.66878978 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.64437603 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.64437603 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.64437603 |
| 62 | regulation of bile acid biosynthetic process (GO:0070857) | 3.61107761 |
| 63 | positive regulation of actin filament depolymerization (GO:0030836) | 3.56255784 |
| 64 | otic vesicle formation (GO:0030916) | 3.56183960 |
| 65 | nucleotide transmembrane transport (GO:1901679) | 3.52433505 |
| 66 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.52206233 |
| 67 | regulation of cholesterol metabolic process (GO:0090181) | 3.52083775 |
| 68 | axonemal dynein complex assembly (GO:0070286) | 3.51390308 |
| 69 | glyoxylate metabolic process (GO:0046487) | 3.50700326 |
| 70 | regulation of cardioblast differentiation (GO:0051890) | 3.47982186 |
| 71 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.47662901 |
| 72 | platelet dense granule organization (GO:0060155) | 3.43797469 |
| 73 | omega-hydroxylase P450 pathway (GO:0097267) | 3.42319546 |
| 74 | dopamine biosynthetic process (GO:0042416) | 3.42013109 |
| 75 | regulation of cardioblast proliferation (GO:0003264) | 3.38652185 |
| 76 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.38652185 |
| 77 | aromatic amino acid family catabolic process (GO:0009074) | 3.38643133 |
| 78 | artery smooth muscle contraction (GO:0014824) | 3.38480859 |
| 79 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.37654601 |
| 80 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 3.36745391 |
| 81 | flavonoid metabolic process (GO:0009812) | 3.36366883 |
| 82 | pharyngeal system development (GO:0060037) | 3.33077127 |
| 83 | negative regulation of lipid storage (GO:0010888) | 3.31882610 |
| 84 | lateral sprouting from an epithelium (GO:0060601) | 3.29690905 |
| 85 | toxin transport (GO:1901998) | 3.27605768 |
| 86 | midbrain development (GO:0030901) | 3.26859046 |
| 87 | removal of superoxide radicals (GO:0019430) | 3.26791176 |
| 88 | cellular response to superoxide (GO:0071451) | 3.26791176 |
| 89 | cellular response to oxygen radical (GO:0071450) | 3.26791176 |
| 90 | prostaglandin metabolic process (GO:0006693) | 3.25643297 |
| 91 | prostanoid metabolic process (GO:0006692) | 3.25643297 |
| 92 | generation of neurons (GO:0048699) | 3.24246139 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.18366008 |
| 94 | positive regulation of sterol transport (GO:0032373) | 3.16940448 |
| 95 | positive regulation of cholesterol transport (GO:0032376) | 3.16940448 |
| 96 | ATP synthesis coupled proton transport (GO:0015986) | 3.16774243 |
| 97 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.16774243 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.16523009 |
| 99 | regulation of alkaline phosphatase activity (GO:0010692) | 3.15738254 |
| 100 | somatic stem cell division (GO:0048103) | 3.14743166 |
| 101 | bile acid biosynthetic process (GO:0006699) | 3.12739370 |
| 102 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.12458858 |
| 103 | cysteine metabolic process (GO:0006534) | 3.11984190 |
| 104 | negative regulation of chemokine production (GO:0032682) | 3.11792345 |
| 105 | nephron epithelium morphogenesis (GO:0072088) | 3.11100077 |
| 106 | nephron tubule morphogenesis (GO:0072078) | 3.11100077 |
| 107 | myoblast migration (GO:0051451) | 3.10186750 |
| 108 | tonic smooth muscle contraction (GO:0014820) | 3.08229133 |
| 109 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.08048058 |
| 110 | cranial suture morphogenesis (GO:0060363) | 3.07931595 |
| 111 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.07322059 |
| 112 | * purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.07322059 |
| 113 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 3.06816810 |
| 114 | positive regulation of cholesterol efflux (GO:0010875) | 3.05705574 |
| 115 | catechol-containing compound biosynthetic process (GO:0009713) | 3.04873541 |
| 116 | catecholamine biosynthetic process (GO:0042423) | 3.04873541 |
| 117 | * xenobiotic metabolic process (GO:0006805) | 3.03909922 |
| 118 | energy homeostasis (GO:0097009) | 3.02413926 |
| 119 | cholesterol efflux (GO:0033344) | 3.01559073 |
| 120 | aldehyde catabolic process (GO:0046185) | 3.01260620 |
| 121 | androgen biosynthetic process (GO:0006702) | 3.00206243 |
| 122 | prostate gland growth (GO:0060736) | 3.00018966 |
| 123 | epoxygenase P450 pathway (GO:0019373) | 2.98857806 |
| 124 | cardiovascular system development (GO:0072358) | 2.98299897 |
| 125 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.97249694 |
| 126 | organ growth (GO:0035265) | 2.97049625 |
| 127 | neuron fate determination (GO:0048664) | 2.96773920 |
| 128 | drug catabolic process (GO:0042737) | 2.96035999 |
| 129 | branch elongation of an epithelium (GO:0060602) | 2.94773480 |
| 130 | acute-phase response (GO:0006953) | 2.90344012 |
| 131 | sulfate transmembrane transport (GO:1902358) | 2.87064612 |
| 132 | positive regulation of meiosis (GO:0045836) | 2.86219263 |
| 133 | positive regulation of meiotic cell cycle (GO:0051446) | 2.82962379 |
| 134 | smooth muscle tissue development (GO:0048745) | 2.81619335 |
| 135 | relaxation of cardiac muscle (GO:0055119) | 2.81311803 |
| 136 | regulation of superoxide metabolic process (GO:0090322) | 2.81171860 |
| 137 | tyrosine metabolic process (GO:0006570) | 2.80012980 |
| 138 | epithelial cilium movement (GO:0003351) | 2.76932563 |
| 139 | positive regulation of blood coagulation (GO:0030194) | 2.76471432 |
| 140 | positive regulation of hemostasis (GO:1900048) | 2.76471432 |
| 141 | somite development (GO:0061053) | 2.76006584 |
| 142 | amyloid precursor protein catabolic process (GO:0042987) | 2.75926454 |
| 143 | desmosome organization (GO:0002934) | 2.75893252 |
| 144 | alpha-linolenic acid metabolic process (GO:0036109) | 2.74657429 |
| 145 | positive regulation of pseudopodium assembly (GO:0031274) | 2.73574823 |
| 146 | head development (GO:0060322) | 2.73459611 |
| 147 | cardiac ventricle morphogenesis (GO:0003208) | 2.72488603 |
| 148 | surfactant homeostasis (GO:0043129) | 2.71728232 |
| 149 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.69704027 |
| 150 | glomerulus development (GO:0032835) | 2.69643818 |
| 151 | negative regulation of fibrinolysis (GO:0051918) | 2.68301224 |
| 152 | bile acid metabolic process (GO:0008206) | 2.67609646 |
| 153 | synaptic transmission, cholinergic (GO:0007271) | 2.67006365 |
| 154 | kidney morphogenesis (GO:0060993) | 2.66317704 |
| 155 | tryptophan catabolic process (GO:0006569) | 2.66100770 |
| 156 | indole-containing compound catabolic process (GO:0042436) | 2.66100770 |
| 157 | indolalkylamine catabolic process (GO:0046218) | 2.66100770 |
| 158 | myoblast fusion (GO:0007520) | 2.65805671 |
| 159 | renal tubule morphogenesis (GO:0061333) | 2.65474488 |
| 160 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.65243287 |
| 161 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.64744371 |
| 162 | embryonic body morphogenesis (GO:0010172) | 2.64709584 |
| 163 | collagen fibril organization (GO:0030199) | 2.62387395 |
| 164 | polyamine biosynthetic process (GO:0006596) | 2.61260975 |
| 165 | anterograde synaptic vesicle transport (GO:0048490) | 2.58506004 |
| 166 | organic cation transport (GO:0015695) | 2.58394175 |
| 167 | positive regulation of canonical Wnt signaling pathway (GO:0090263) | 2.58356918 |
| 168 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.57668200 |
| 169 | face morphogenesis (GO:0060325) | 2.55461717 |
| 170 | cyclic nucleotide catabolic process (GO:0009214) | 2.52642656 |
| 171 | embryonic digestive tract morphogenesis (GO:0048557) | 2.51118299 |
| 172 | retina layer formation (GO:0010842) | 2.50246134 |
| 173 | cardiac chamber morphogenesis (GO:0003206) | 2.45703705 |
| 174 | DNA integration (GO:0015074) | 2.43860471 |
| 175 | intraciliary transport (GO:0042073) | 2.42779690 |
| 176 | establishment of tissue polarity (GO:0007164) | 2.41704120 |
| 177 | establishment of planar polarity (GO:0001736) | 2.41704120 |
| 178 | Notch signaling involved in heart development (GO:0061314) | 2.40706995 |
| 179 | mesenchymal cell development (GO:0014031) | 2.39499150 |
| 180 | cell differentiation involved in metanephros development (GO:0072202) | 2.39062407 |
| 181 | toxin metabolic process (GO:0009404) | 2.38989786 |
| 182 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.35707596 |
| 183 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.35363278 |
| 184 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.34236789 |
| 185 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.33893559 |
| 186 | axis elongation (GO:0003401) | 2.33700342 |
| 187 | pyrimidine dimer repair (GO:0006290) | 2.33433598 |
| 188 | sympathetic nervous system development (GO:0048485) | 2.33385604 |
| 189 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.33254253 |
| 190 | response to nitrosative stress (GO:0051409) | 11.7908073 |
| 191 | xenobiotic catabolic process (GO:0042178) | 11.0017120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.47160888 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.31155989 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.97604626 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.89903069 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.79763821 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73568402 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70198834 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47953328 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.34119721 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.04221596 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.83389707 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68322606 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.55109417 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.52668727 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.52418097 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.45830043 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.39938644 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36712828 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.31455535 |
| 20 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.25883251 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.24885087 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22170226 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.19783917 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17801416 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02978994 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 2.02940106 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97745625 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96149052 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.89049709 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86799452 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86434407 |
| 32 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86434407 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86097618 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.84633580 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83427275 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.82991484 |
| 37 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.81021530 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.81010175 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78164990 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.74391662 |
| 41 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.74156212 |
| 42 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74156212 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.72284234 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.70046102 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.69848720 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.69848720 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69096386 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67673614 |
| 49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.67349934 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66095321 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.63567810 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.63214737 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61063398 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.58371503 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55408246 |
| 56 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.50906716 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49471641 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49317969 |
| 59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.48092518 |
| 60 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47680578 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.44968417 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.44290896 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43278835 |
| 64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.43131938 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41775788 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40616960 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40467604 |
| 68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40210108 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38466816 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36415532 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35792660 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.33994110 |
| 73 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33887685 |
| 74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.32636805 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31626128 |
| 76 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29890757 |
| 77 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.29859671 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27564973 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.27481965 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26869890 |
| 81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26869890 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25095781 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23816683 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23561151 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23031343 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22911494 |
| 87 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22731552 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22625350 |
| 89 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.22169818 |
| 90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21810669 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21272675 |
| 92 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21082486 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20869083 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20702841 |
| 95 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.20205777 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19616466 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19578519 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19500220 |
| 99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18659351 |
| 100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18321570 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17465930 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15495068 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15437850 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15177201 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13722761 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12888673 |
| 107 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11707655 |
| 108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11256351 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11206986 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10955517 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.10385308 |
| 112 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10094426 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09231179 |
| 114 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08005935 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07953984 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05941853 |
| 117 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05380294 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05108320 |
| 119 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03919537 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02848202 |
| 121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02673530 |
| 122 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01284243 |
| 123 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99279119 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99005820 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98456634 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98409271 |
| 127 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97909851 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97756888 |
| 129 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.97219583 |
| 130 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97072159 |
| 131 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96718547 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95270686 |
| 133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93700696 |
| 134 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91513454 |
| 135 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91443633 |
| 136 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.91286781 |
| 137 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.91286781 |
| 138 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.91286781 |
| 139 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90430759 |
| 140 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89615170 |
| 141 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89319651 |
| 142 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87390476 |
| 143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86158496 |
| 144 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85026999 |
| 145 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.84979975 |
| 146 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83077491 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82515918 |
| 148 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82077982 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81367128 |
| 150 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80942784 |
| 151 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80842925 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80603582 |
| 153 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80548186 |
| 154 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.80331126 |
| 155 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.79846089 |
| 156 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79340588 |
| 157 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.79128333 |
| 158 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.78673695 |
| 159 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.76783857 |
| 160 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74613940 |
| 161 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.74554317 |
| 162 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.71253631 |
| 163 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71053387 |
| 164 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71033827 |
| 165 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.71022042 |
| 166 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70935608 |
| 167 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.67665910 |
| 168 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67264942 |
| 169 | FUS_26573619_Chip-Seq_HEK293_Human | 0.66475843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19234135 |
| 2 | MP0008789_abnormal_olfactory_epithelium | 5.02884351 |
| 3 | MP0010030_abnormal_orbit_morphology | 4.92663967 |
| 4 | MP0005171_absent_coat_pigmentation | 4.74259827 |
| 5 | MP0005394_taste/olfaction_phenotype | 4.55838702 |
| 6 | MP0005499_abnormal_olfactory_system | 4.55838702 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 4.23487223 |
| 8 | MP0001346_abnormal_lacrimal_gland | 3.91435961 |
| 9 | MP0005365_abnormal_bile_salt | 3.89380105 |
| 10 | MP0009840_abnormal_foam_cell | 3.65717954 |
| 11 | MP0005503_abnormal_tendon_morphology | 3.56481600 |
| 12 | MP0005083_abnormal_biliary_tract | 3.34491001 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 3.09687358 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.90821822 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.76325842 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.71253471 |
| 17 | MP0000579_abnormal_nail_morphology | 2.55957804 |
| 18 | MP0002254_reproductive_system_inflammat | 2.55282981 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.44961408 |
| 20 | MP0003279_aneurysm | 2.38031789 |
| 21 | MP0005360_urolithiasis | 2.35194600 |
| 22 | MP0002282_abnormal_trachea_morphology | 2.17925788 |
| 23 | MP0003186_abnormal_redox_activity | 2.17007564 |
| 24 | MP0000678_abnormal_parathyroid_gland | 2.10697336 |
| 25 | MP0000762_abnormal_tongue_morphology | 2.07403795 |
| 26 | MP0000566_synostosis | 2.01365229 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 2.00471215 |
| 28 | MP0000631_abnormal_neuroendocrine_gland | 1.94907536 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.86372393 |
| 30 | MP0004272_abnormal_basement_membrane | 1.82668158 |
| 31 | MP0001984_abnormal_olfaction | 1.77929750 |
| 32 | MP0002009_preneoplasia | 1.76756359 |
| 33 | MP0002108_abnormal_muscle_morphology | 1.69290579 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.68791151 |
| 35 | MP0004142_abnormal_muscle_tone | 1.66883016 |
| 36 | MP0002233_abnormal_nose_morphology | 1.65858593 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.64500990 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.58854039 |
| 39 | MP0001324_abnormal_eye_pigmentation | 1.50653091 |
| 40 | MP0002697_abnormal_eye_size | 1.48530474 |
| 41 | MP0008872_abnormal_physiological_respon | 1.46378382 |
| 42 | MP0002928_abnormal_bile_duct | 1.46319074 |
| 43 | MP0008057_abnormal_DNA_replication | 1.45288899 |
| 44 | MP0004043_abnormal_pH_regulation | 1.44446176 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.41676160 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.40566553 |
| 47 | MP0001177_atelectasis | 1.40443180 |
| 48 | MP0000639_abnormal_adrenal_gland | 1.38593553 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.34980798 |
| 50 | MP0005595_abnormal_vascular_smooth | 1.33958494 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.32242142 |
| 52 | MP0009053_abnormal_anal_canal | 1.31667156 |
| 53 | MP0005275_abnormal_skin_tensile | 1.30664566 |
| 54 | MP0005248_abnormal_Harderian_gland | 1.29710238 |
| 55 | MP0005410_abnormal_fertilization | 1.26039150 |
| 56 | MP0003690_abnormal_glial_cell | 1.24612937 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.22346818 |
| 58 | MP0004134_abnormal_chest_morphology | 1.21301061 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.19908561 |
| 60 | MP0000516_abnormal_urinary_system | 1.18487343 |
| 61 | MP0005367_renal/urinary_system_phenotyp | 1.18487343 |
| 62 | MP0000613_abnormal_salivary_gland | 1.17982552 |
| 63 | MP0002938_white_spotting | 1.17751913 |
| 64 | MP0006054_spinal_hemorrhage | 1.16509823 |
| 65 | MP0005332_abnormal_amino_acid | 1.16322725 |
| 66 | MP0003935_abnormal_craniofacial_develop | 1.15518898 |
| 67 | MP0001286_abnormal_eye_development | 1.13887486 |
| 68 | MP0000383_abnormal_hair_follicle | 1.13132140 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.12744820 |
| 70 | MP0001968_abnormal_touch/_nociception | 1.12652195 |
| 71 | MP0000049_abnormal_middle_ear | 1.12405750 |
| 72 | MP0002249_abnormal_larynx_morphology | 1.12330112 |
| 73 | MP0001299_abnormal_eye_distance/ | 1.12021787 |
| 74 | MP0005508_abnormal_skeleton_morphology | 1.09630601 |
| 75 | MP0003195_calcinosis | 1.09042933 |
| 76 | MP0000230_abnormal_systemic_arterial | 1.06457412 |
| 77 | MP0000462_abnormal_digestive_system | 1.05885632 |
| 78 | MP0005187_abnormal_penis_morphology | 1.03563911 |
| 79 | MP0005408_hypopigmentation | 1.02536281 |
| 80 | MP0002932_abnormal_joint_morphology | 1.02238985 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.00473989 |
| 82 | MP0000026_abnormal_inner_ear | 0.99135467 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.98939560 |
| 84 | MP0002109_abnormal_limb_morphology | 0.98770282 |
| 85 | MP0002132_abnormal_respiratory_system | 0.97937988 |
| 86 | MP0003252_abnormal_bile_duct | 0.96580186 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.95675929 |
| 88 | MP0005377_hearing/vestibular/ear_phenot | 0.95429852 |
| 89 | MP0003878_abnormal_ear_physiology | 0.95429852 |
| 90 | MP0002135_abnormal_kidney_morphology | 0.94753693 |
| 91 | MP0005451_abnormal_body_composition | 0.94112775 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.93610784 |
| 93 | MP0006292_abnormal_olfactory_placode | 0.93280110 |
| 94 | MP0001486_abnormal_startle_reflex | 0.92752779 |
| 95 | MP0000534_abnormal_ureter_morphology | 0.92434315 |
| 96 | MP0003075_altered_response_to | 0.92053892 |
| 97 | MP0008995_early_reproductive_senescence | 0.90727469 |
| 98 | MP0009250_abnormal_appendicular_skeleto | 0.89349197 |
| 99 | MP0008775_abnormal_heart_ventricle | 0.89132303 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.87860653 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.87323615 |
| 102 | MP0003941_abnormal_skin_development | 0.87236065 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.86710051 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.85872949 |
| 105 | MP0000647_abnormal_sebaceous_gland | 0.84786862 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.84678770 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.84460367 |
| 108 | MP0002127_abnormal_cardiovascular_syste | 0.84285337 |
| 109 | MP0009745_abnormal_behavioral_response | 0.83244987 |
| 110 | MP0001666_abnormal_nutrient_absorption | 0.82830689 |
| 111 | MP0001270_distended_abdomen | 0.82104211 |
| 112 | MP0005195_abnormal_posterior_eye | 0.81903218 |
| 113 | MP0000427_abnormal_hair_cycle | 0.81824281 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.81724606 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.81724517 |
| 116 | MP0002116_abnormal_craniofacial_bone | 0.81153851 |
| 117 | MP0003943_abnormal_hepatobiliary_system | 0.80939065 |
| 118 | MP0002113_abnormal_skeleton_development | 0.80241596 |
| 119 | MP0002115_abnormal_skeleton_extremities | 0.79906369 |
| 120 | MP0001293_anophthalmia | 0.79403485 |
| 121 | MP0003385_abnormal_body_wall | 0.79218232 |
| 122 | MP0002295_abnormal_pulmonary_circulatio | 0.78731856 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.78332441 |
| 124 | MP0000428_abnormal_craniofacial_morphol | 0.78262010 |
| 125 | MP0002060_abnormal_skin_morphology | 0.77817758 |
| 126 | MP0002133_abnormal_respiratory_system | 0.76745696 |
| 127 | MP0005388_respiratory_system_phenotype | 0.76745696 |
| 128 | MP0003938_abnormal_ear_development | 0.76354572 |
| 129 | MP0002751_abnormal_autonomic_nervous | 0.76100829 |
| 130 | MP0001853_heart_inflammation | 0.75111808 |
| 131 | MP0002735_abnormal_chemical_nociception | 0.74427410 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.73680851 |
| 133 | MP0003705_abnormal_hypodermis_morpholog | 0.73530181 |
| 134 | MP0003045_fibrosis | 0.73388054 |
| 135 | MP0004085_abnormal_heartbeat | 0.71896907 |
| 136 | MP0002177_abnormal_outer_ear | 0.71694088 |
| 137 | MP0005023_abnormal_wound_healing | 0.69934596 |
| 138 | MP0003937_abnormal_limbs/digits/tail_de | 0.69732274 |
| 139 | MP0000432_abnormal_head_morphology | 0.69426863 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.69192816 |
| 141 | MP0010678_abnormal_skin_adnexa | 0.68951585 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.68516436 |
| 143 | MP0000609_abnormal_liver_physiology | 0.68421049 |
| 144 | MP0001756_abnormal_urination | 0.68400485 |
| 145 | MP0002006_tumorigenesis | 0.66096844 |
| 146 | MP0005319_abnormal_enzyme/_coenzyme | 0.65870738 |
| 147 | MP0003755_abnormal_palate_morphology | 0.65831786 |
| 148 | MP0003453_abnormal_keratinocyte_physiol | 0.61265410 |
| 149 | MP0004381_abnormal_hair_follicle | 0.60215490 |
| 150 | MP0001905_abnormal_dopamine_level | 0.59630618 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.57933948 |
| 152 | MP0003942_abnormal_urinary_system | 0.55695741 |
| 153 | MP0009763_increased_sensitivity_to | 0.54694604 |
| 154 | MP0005164_abnormal_response_to | 0.54560303 |
| 155 | MP0004883_abnormal_blood_vessel | 0.54541096 |
| 156 | MP0009643_abnormal_urine_homeostasis | 0.52081743 |
| 157 | MP0000537_abnormal_urethra_morphology | 0.50720632 |
| 158 | MP0001879_abnormal_lymphatic_vessel | 0.46274865 |
| 159 | MP0002234_abnormal_pharynx_morphology | 0.46095867 |
| 160 | MP0009278_abnormal_bone_marrow | 0.45554394 |
| 161 | MP0009765_abnormal_xenobiotic_induced | 0.45509187 |
| 162 | MP0003011_delayed_dark_adaptation | 0.45015261 |
| 163 | MP0003115_abnormal_respiratory_system | 0.44420921 |
| 164 | MP0003724_increased_susceptibility_to | 0.43820075 |
| 165 | MP0005166_decreased_susceptibility_to | 0.43071405 |
| 166 | MP0000163_abnormal_cartilage_morphology | 0.40228821 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.39538525 |
| 168 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38606508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomach cancer (HP:0012126) | 7.04916432 |
| 2 | Concave nail (HP:0001598) | 6.33082191 |
| 3 | Arterial tortuosity (HP:0005116) | 5.36499732 |
| 4 | Lip pit (HP:0100267) | 5.35525094 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.28226067 |
| 6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.25334391 |
| 7 | Vascular tortuosity (HP:0004948) | 4.71733278 |
| 8 | Keratoconus (HP:0000563) | 4.39638534 |
| 9 | Increased corneal curvature (HP:0100692) | 4.39638534 |
| 10 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.26978080 |
| 11 | Bifid scrotum (HP:0000048) | 4.09010089 |
| 12 | Rhinitis (HP:0012384) | 4.05569658 |
| 13 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.04233635 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 3.92612534 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.68246064 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.59445519 |
| 17 | Prostate neoplasm (HP:0100787) | 3.59300465 |
| 18 | Turricephaly (HP:0000262) | 3.58684533 |
| 19 | Renal tubular acidosis (HP:0001947) | 3.57568011 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.56661866 |
| 21 | Aortic dissection (HP:0002647) | 3.55222135 |
| 22 | Ridged nail (HP:0001807) | 3.52764542 |
| 23 | Humeroradial synostosis (HP:0003041) | 3.52742251 |
| 24 | Synostosis involving the elbow (HP:0003938) | 3.52742251 |
| 25 | Xanthomatosis (HP:0000991) | 3.51809479 |
| 26 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 3.49090356 |
| 27 | Focal motor seizures (HP:0011153) | 3.39905489 |
| 28 | Pulmonary artery stenosis (HP:0004415) | 3.35141994 |
| 29 | Chronic hepatic failure (HP:0100626) | 3.34237634 |
| 30 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.29340329 |
| 31 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.27666316 |
| 32 | Aqueductal stenosis (HP:0002410) | 3.27482233 |
| 33 | Partial duplication of the phalanx of hand (HP:0009999) | 3.22723676 |
| 34 | Chronic bronchitis (HP:0004469) | 3.18069099 |
| 35 | Papilledema (HP:0001085) | 3.14350108 |
| 36 | Fibular aplasia (HP:0002990) | 3.13003421 |
| 37 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 3.12919250 |
| 38 | Midline defect of the nose (HP:0004122) | 3.12514391 |
| 39 | Partial duplication of thumb phalanx (HP:0009944) | 3.09178796 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.96472850 |
| 41 | Abnormal ciliary motility (HP:0012262) | 2.96236765 |
| 42 | Epidermoid cyst (HP:0200040) | 2.93461315 |
| 43 | Urethral obstruction (HP:0000796) | 2.89476336 |
| 44 | Short hallux (HP:0010109) | 2.87001999 |
| 45 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.83795851 |
| 46 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.79147364 |
| 47 | Short 1st metacarpal (HP:0010034) | 2.79147364 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.79113383 |
| 49 | 11 pairs of ribs (HP:0000878) | 2.78887573 |
| 50 | Hypophosphatemic rickets (HP:0004912) | 2.76934808 |
| 51 | Soft skin (HP:0000977) | 2.75015252 |
| 52 | Fat malabsorption (HP:0002630) | 2.71399030 |
| 53 | Hypoalphalipoproteinemia (HP:0003233) | 2.68785172 |
| 54 | Hyperammonemia (HP:0001987) | 2.64955822 |
| 55 | Recurrent corneal erosions (HP:0000495) | 2.64655627 |
| 56 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.64390506 |
| 57 | Bronchomalacia (HP:0002780) | 2.64252235 |
| 58 | Vaginal atresia (HP:0000148) | 2.63262591 |
| 59 | Abnormal hemoglobin (HP:0011902) | 2.63104021 |
| 60 | Prolonged partial thromboplastin time (HP:0003645) | 2.63026121 |
| 61 | Genital tract atresia (HP:0001827) | 2.62836891 |
| 62 | Hyperglycinuria (HP:0003108) | 2.61329385 |
| 63 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.61251417 |
| 64 | Aplasia of the phalanges of the hand (HP:0009802) | 2.61251417 |
| 65 | Aplasia involving bones of the extremities (HP:0009825) | 2.61251417 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.59978078 |
| 67 | Abnormality of midbrain morphology (HP:0002418) | 2.59978078 |
| 68 | Rickets (HP:0002748) | 2.58556508 |
| 69 | Seborrheic dermatitis (HP:0001051) | 2.57612785 |
| 70 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.57546996 |
| 71 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.57455939 |
| 72 | Stenosis of the external auditory canal (HP:0000402) | 2.56988630 |
| 73 | Broad distal phalanx of finger (HP:0009836) | 2.56194457 |
| 74 | Hyperventilation (HP:0002883) | 2.55300409 |
| 75 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.53772284 |
| 76 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.53772284 |
| 77 | Ketosis (HP:0001946) | 2.51479885 |
| 78 | Steatorrhea (HP:0002570) | 2.48705758 |
| 79 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47809068 |
| 80 | Abnormality of glycine metabolism (HP:0010895) | 2.47809068 |
| 81 | Broad metatarsal (HP:0001783) | 2.45093577 |
| 82 | Abnormality of the 2nd finger (HP:0004100) | 2.44688757 |
| 83 | Distal lower limb muscle weakness (HP:0009053) | 2.42763467 |
| 84 | Hypobetalipoproteinemia (HP:0003563) | 2.41771597 |
| 85 | Chronic sinusitis (HP:0011109) | 2.41132557 |
| 86 | Abnormality of the 1st metacarpal (HP:0010009) | 2.40503102 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40064073 |
| 88 | Generalized aminoaciduria (HP:0002909) | 2.38068102 |
| 89 | Hypolipoproteinemia (HP:0010981) | 2.37889363 |
| 90 | Alopecia of scalp (HP:0002293) | 2.36628911 |
| 91 | True hermaphroditism (HP:0010459) | 2.36318990 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 2.33892969 |
| 93 | Anencephaly (HP:0002323) | 2.33533337 |
| 94 | Ketoacidosis (HP:0001993) | 2.33050717 |
| 95 | Mesomelia (HP:0003027) | 2.30166276 |
| 96 | Abnormal tarsal ossification (HP:0008369) | 2.28355135 |
| 97 | Tarsal synostosis (HP:0008368) | 2.27226258 |
| 98 | Aplasia of the musculature (HP:0100854) | 2.25049061 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 2.24367232 |
| 100 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.22574491 |
| 101 | Complement deficiency (HP:0004431) | 2.21919314 |
| 102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.20334203 |
| 103 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.20334203 |
| 104 | Hydroureter (HP:0000072) | 2.19724594 |
| 105 | Abnormality of the renal medulla (HP:0100957) | 2.18581857 |
| 106 | Posterior subcapsular cataract (HP:0007787) | 2.18326199 |
| 107 | Focal segmental glomerulosclerosis (HP:0000097) | 2.17401315 |
| 108 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17284930 |
| 109 | Hypoplasia of the ulna (HP:0003022) | 2.16923184 |
| 110 | Acne (HP:0001061) | 2.14876664 |
| 111 | Stillbirth (HP:0003826) | 2.14260069 |
| 112 | Short nail (HP:0001799) | 2.13965521 |
| 113 | Pancreatic cysts (HP:0001737) | 2.12996704 |
| 114 | Abnormal foot bone ossification (HP:0010675) | 2.12713176 |
| 115 | Fibular hypoplasia (HP:0003038) | 2.11740745 |
| 116 | Pili torti (HP:0003777) | 2.11026226 |
| 117 | Nephritis (HP:0000123) | 2.10260413 |
| 118 | Hyperthyroidism (HP:0000836) | 2.10244039 |
| 119 | Abnormality of the renal cortex (HP:0011035) | 2.09529067 |
| 120 | Bell-shaped thorax (HP:0001591) | 2.08998033 |
| 121 | Renal hypoplasia (HP:0000089) | 2.08107736 |
| 122 | Alveolar cell carcinoma (HP:0006519) | 2.07947238 |
| 123 | Pancreatic fibrosis (HP:0100732) | 2.07876627 |
| 124 | Hypercholesterolemia (HP:0003124) | 2.07746316 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 2.06829191 |
| 126 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06611185 |
| 127 | Abnormality of the labia minora (HP:0012880) | 2.05254046 |
| 128 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.05201990 |
| 129 | Spondylolisthesis (HP:0003302) | 2.04383468 |
| 130 | Occipital encephalocele (HP:0002085) | 2.04359636 |
| 131 | Meningioma (HP:0002858) | 2.04172390 |
| 132 | Short tibia (HP:0005736) | 2.03957143 |
| 133 | Buphthalmos (HP:0000557) | 2.03261697 |
| 134 | Cerebral palsy (HP:0100021) | 2.01722955 |
| 135 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.01229640 |
| 136 | Synostosis involving bones of the feet (HP:0009140) | 2.01229640 |
| 137 | Nephronophthisis (HP:0000090) | 2.00560379 |
| 138 | Myocardial infarction (HP:0001658) | 2.00227652 |
| 139 | Down-sloping shoulders (HP:0200021) | 1.97971934 |
| 140 | Enlarged epiphyses (HP:0010580) | 1.96945606 |
| 141 | Corneal erosion (HP:0200020) | 1.96722598 |
| 142 | Prolonged neonatal jaundice (HP:0006579) | 1.95898608 |
| 143 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.95280556 |
| 144 | Abnormality of the parathyroid morphology (HP:0011766) | 1.94959202 |
| 145 | Esophageal atresia (HP:0002032) | 1.94380725 |
| 146 | Stage 5 chronic kidney disease (HP:0003774) | 1.94293708 |
| 147 | Bowing of the arm (HP:0006488) | 1.93969609 |
| 148 | Bowed forearm bones (HP:0003956) | 1.93969609 |
| 149 | Intellectual disability, moderate (HP:0002342) | 1.93436872 |
| 150 | Femoral bowing (HP:0002980) | 1.93170782 |
| 151 | Hypoplastic scapulae (HP:0000882) | 1.92882746 |
| 152 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.92882746 |
| 153 | Cutaneous finger syndactyly (HP:0010554) | 1.91484052 |
| 154 | Hyperglycinemia (HP:0002154) | 1.91337624 |
| 155 | Pancreatitis (HP:0001733) | 1.90603630 |
| 156 | Sleep apnea (HP:0010535) | 1.88984442 |
| 157 | Abnormality of cochlea (HP:0000375) | 1.88703026 |
| 158 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.88294430 |
| 159 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.87274330 |
| 160 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.86944494 |
| 161 | Preauricular pit (HP:0004467) | 1.86462731 |
| 162 | Periauricular skin pits (HP:0100277) | 1.86462731 |
| 163 | Renal tubular dysfunction (HP:0000124) | 1.85988698 |
| 164 | Congenital primary aphakia (HP:0007707) | 1.85603468 |
| 165 | Cupped ear (HP:0000378) | 1.84492972 |
| 166 | Pigmentary retinal degeneration (HP:0001146) | 1.84151336 |
| 167 | Gait imbalance (HP:0002141) | 1.82962237 |
| 168 | Abnormality of complement system (HP:0005339) | 1.82548655 |
| 169 | Sparse lateral eyebrow (HP:0005338) | 1.82521311 |
| 170 | Mixed hearing impairment (HP:0000410) | 1.82120257 |
| 171 | Hypoplastic labia majora (HP:0000059) | 1.81110957 |
| 172 | Abnormality of the nasolacrimal system (HP:0000614) | 1.77720600 |
| 173 | Sparse scalp hair (HP:0002209) | 1.76466041 |
| 174 | Glomerulosclerosis (HP:0000096) | 1.75124585 |
| 175 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75099172 |
| 176 | Abnormal finger flexion creases (HP:0006143) | 1.74579893 |
| 177 | Exostoses (HP:0100777) | 1.72177215 |
| 178 | Absent phalangeal crease (HP:0006109) | 1.71870961 |
| 179 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.71472479 |
| 180 | Abnormality of the vitreous humor (HP:0004327) | 1.71119787 |
| 181 | Bilateral microphthalmos (HP:0007633) | 1.69958372 |
| 182 | Abnormality of the lacrimal duct (HP:0011481) | 1.69800180 |
| 183 | Nephrotic syndrome (HP:0000100) | 1.66821819 |
| 184 | Glomerulonephritis (HP:0000099) | 1.66055743 |
| 185 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.64608139 |
| 186 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.64491191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 6.45780345 |
| 2 | RIPK1 | 4.48303392 |
| 3 | MAP3K3 | 4.09701994 |
| 4 | ZAK | 3.55940293 |
| 5 | PRPF4B | 3.21796500 |
| 6 | BCKDK | 2.88443978 |
| 7 | MAPK15 | 2.70768301 |
| 8 | ERN1 | 2.70009229 |
| 9 | TAOK2 | 2.37413327 |
| 10 | MAP3K2 | 2.31031237 |
| 11 | FRK | 2.31028465 |
| 12 | MAP2K3 | 2.12482132 |
| 13 | MAP2K2 | 2.10547062 |
| 14 | MST4 | 2.05272896 |
| 15 | RPS6KB2 | 2.04220094 |
| 16 | LMTK2 | 2.00885359 |
| 17 | PAK3 | 1.98818629 |
| 18 | TNIK | 1.78835401 |
| 19 | HIPK2 | 1.77447184 |
| 20 | TAOK1 | 1.76095952 |
| 21 | DDR2 | 1.74095555 |
| 22 | TESK1 | 1.74021365 |
| 23 | TGFBR1 | 1.73628713 |
| 24 | PBK | 1.72197830 |
| 25 | EPHB2 | 1.72060870 |
| 26 | SIK1 | 1.69423572 |
| 27 | EPHB1 | 1.63502503 |
| 28 | TIE1 | 1.62038011 |
| 29 | PNCK | 1.52624155 |
| 30 | MAP3K4 | 1.49991370 |
| 31 | LRRK2 | 1.43667523 |
| 32 | TEC | 1.41528258 |
| 33 | SGK2 | 1.41441755 |
| 34 | WEE1 | 1.38729067 |
| 35 | CLK1 | 1.38550056 |
| 36 | DYRK3 | 1.35768014 |
| 37 | WNK3 | 1.32459752 |
| 38 | INSRR | 1.31941256 |
| 39 | STK38L | 1.28243695 |
| 40 | MAP2K6 | 1.28206619 |
| 41 | MAPKAPK5 | 1.23587477 |
| 42 | MAP3K14 | 1.21913639 |
| 43 | MAP3K11 | 1.21616459 |
| 44 | GRK1 | 1.21610387 |
| 45 | IRAK3 | 1.20788048 |
| 46 | LATS1 | 1.15196152 |
| 47 | NEK6 | 1.14785612 |
| 48 | EPHA2 | 1.13895467 |
| 49 | NLK | 1.13034542 |
| 50 | FGFR2 | 1.11894445 |
| 51 | RPS6KA4 | 1.10957297 |
| 52 | SGK223 | 1.10775668 |
| 53 | SGK494 | 1.10775668 |
| 54 | AKT3 | 1.07714501 |
| 55 | MAP2K1 | 1.07015652 |
| 56 | VRK1 | 1.04667562 |
| 57 | MST1R | 1.02951233 |
| 58 | PRKG2 | 1.02671754 |
| 59 | BMPR1B | 1.02492422 |
| 60 | YES1 | 1.01450594 |
| 61 | FES | 0.99329984 |
| 62 | PIK3CG | 0.98856641 |
| 63 | CDK6 | 0.96977636 |
| 64 | TYK2 | 0.96794935 |
| 65 | SGK3 | 0.96598860 |
| 66 | MKNK1 | 0.95190321 |
| 67 | GRK7 | 0.92878418 |
| 68 | MAPK12 | 0.90333552 |
| 69 | OXSR1 | 0.87811275 |
| 70 | ERBB4 | 0.87418995 |
| 71 | DYRK1B | 0.87041319 |
| 72 | STK3 | 0.86706511 |
| 73 | ILK | 0.86216074 |
| 74 | TLK1 | 0.84605422 |
| 75 | STK39 | 0.83741771 |
| 76 | IRAK4 | 0.83543410 |
| 77 | NME1 | 0.82090268 |
| 78 | FGFR4 | 0.81311623 |
| 79 | IRAK2 | 0.79255062 |
| 80 | MAPK7 | 0.77984996 |
| 81 | CAMK4 | 0.77944135 |
| 82 | IRAK1 | 0.77916449 |
| 83 | FGFR1 | 0.77649589 |
| 84 | PDK2 | 0.76477722 |
| 85 | ADRBK1 | 0.75652680 |
| 86 | IKBKE | 0.75383316 |
| 87 | EPHA3 | 0.74583241 |
| 88 | PLK3 | 0.74449241 |
| 89 | KIT | 0.73666255 |
| 90 | STK4 | 0.71006283 |
| 91 | CHUK | 0.70049325 |
| 92 | TAF1 | 0.69385978 |
| 93 | ERBB2 | 0.67621508 |
| 94 | PLK2 | 0.67171597 |
| 95 | ITK | 0.66651983 |
| 96 | MAPK13 | 0.65732917 |
| 97 | GSK3A | 0.65448305 |
| 98 | ERBB3 | 0.65395828 |
| 99 | PRKCI | 0.64301082 |
| 100 | PASK | 0.62924920 |
| 101 | BRSK2 | 0.60110158 |
| 102 | CDK3 | 0.59902333 |
| 103 | PRKCE | 0.59473114 |
| 104 | TYRO3 | 0.58811544 |
| 105 | PRKCG | 0.57332730 |
| 106 | VRK2 | 0.57108736 |
| 107 | FER | 0.56804411 |
| 108 | PIK3CA | 0.56739706 |
| 109 | MAPK4 | 0.55594326 |
| 110 | ADRBK2 | 0.55460172 |
| 111 | LIMK1 | 0.54091855 |
| 112 | ABL2 | 0.52509888 |
| 113 | PDGFRA | 0.51104893 |
| 114 | MYLK | 0.50635130 |
| 115 | UHMK1 | 0.50609053 |
| 116 | PTK2B | 0.50261153 |
| 117 | CAMK2G | 0.50117120 |
| 118 | RPS6KA6 | 0.48266685 |
| 119 | MAPKAPK3 | 0.47974475 |
| 120 | MAPKAPK2 | 0.47716391 |
| 121 | CAMK1 | 0.47421795 |
| 122 | MAP4K2 | 0.47340579 |
| 123 | DAPK2 | 0.47330883 |
| 124 | RPS6KC1 | 0.47103210 |
| 125 | RPS6KL1 | 0.47103210 |
| 126 | NUAK1 | 0.45079922 |
| 127 | MAP3K10 | 0.44712275 |
| 128 | TRPM7 | 0.42963997 |
| 129 | CAMK2B | 0.42460668 |
| 130 | PRKCQ | 0.42411220 |
| 131 | PRKG1 | 0.41640548 |
| 132 | BMPR2 | 0.41494016 |
| 133 | EIF2AK2 | 0.41258692 |
| 134 | CCNB1 | 0.40440775 |
| 135 | MAP3K5 | 0.36556009 |
| 136 | PINK1 | 0.36324513 |
| 137 | IKBKB | 0.35176237 |
| 138 | WNK4 | 0.34557103 |
| 139 | RPS6KA2 | 0.34444495 |
| 140 | CAMK2D | 0.33363453 |
| 141 | CAMK2A | 0.32167581 |
| 142 | DYRK1A | 0.31494185 |
| 143 | MAP3K1 | 0.30956963 |
| 144 | JAK1 | 0.30798916 |
| 145 | PRKACA | 0.30658767 |
| 146 | TSSK6 | 0.30646343 |
| 147 | OBSCN | 0.30388267 |
| 148 | CASK | 0.30044285 |
| 149 | MAPK3 | 0.29926947 |
| 150 | PRKD1 | 0.29886863 |
| 151 | STK38 | 0.29100377 |
| 152 | MUSK | 0.28855221 |
| 153 | MAP2K4 | 0.28825670 |
| 154 | ROCK1 | 0.28739608 |
| 155 | MAPK1 | 0.28628544 |
| 156 | CDK8 | 0.28545389 |
| 157 | TTK | 0.27398973 |
| 158 | MATK | 0.27326215 |
| 159 | MKNK2 | 0.26825123 |
| 160 | CSNK1G1 | 0.26391846 |
| 161 | PRKAA1 | 0.25248581 |
| 162 | IGF1R | 0.24998763 |
| 163 | STK10 | 0.24487694 |
| 164 | AKT2 | 0.23051717 |
| 165 | RPS6KA5 | 0.22972787 |
| 166 | PDGFRB | 0.22579509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 5.35083799 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 5.22549389 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 5.03761492 |
| 4 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 4.87411070 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.40292496 |
| 6 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.07828866 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 3.05707244 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.70689387 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69525390 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.59144579 |
| 11 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.55000305 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.46428993 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.32586802 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.27967392 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14388010 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.10227528 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.08112017 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.93458377 |
| 19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.92185118 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.91667490 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.88786809 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.82902858 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76075501 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66515088 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.64257244 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59931305 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48057032 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.47028711 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38429673 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38107447 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36297814 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36027498 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.35500903 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33249402 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31867758 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.30834661 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.30600530 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28550570 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27060496 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25155479 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24978075 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22769663 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.22008014 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20519031 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17841096 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.16823990 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.15422004 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14768156 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14109521 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13690821 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13558467 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12827108 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.11881993 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11338868 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 1.09661208 |
| 56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07439647 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05825938 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04105757 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99522118 |
| 60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99072311 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.95658323 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95066519 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92022981 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87137956 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.87043888 |
| 66 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.86968691 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84733664 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82400712 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81559476 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81487889 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79954129 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76884278 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75233309 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73575721 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71446981 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70791077 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69675984 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67328693 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64597791 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64363936 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63362827 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60307084 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60141491 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.57648956 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.53431188 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52143802 |
| 87 | Taste transduction_Homo sapiens_hsa04742 | 0.51136355 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50255587 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49467757 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48836738 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47397242 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46366416 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.46354465 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.46125120 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45980017 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44931749 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43142960 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42985375 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.42874837 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42832662 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41651879 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40345359 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39822849 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38238951 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37971766 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.37722405 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36992754 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36692985 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35666572 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34553431 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | 0.34465803 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33989732 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33364486 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32902118 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.29545006 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29365270 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28998140 |
| 118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28692420 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27671571 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.27330191 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25460402 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24149112 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.21685120 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.21387674 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21305934 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.19777826 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.17097256 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16478384 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15705840 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15498642 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15223292 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14319300 |
| 133 | Pertussis_Homo sapiens_hsa05133 | 0.13702804 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12134421 |
| 135 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.10872810 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.10362351 |
| 137 | Lysine degradation_Homo sapiens_hsa00310 | 0.09185739 |
| 138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08488261 |
| 139 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08102966 |
| 140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.07922593 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06260419 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05943762 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.05781809 |
| 144 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.05330452 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04733021 |
| 146 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.02467190 |
| 147 | Hepatitis C_Homo sapiens_hsa05160 | 0.02400700 |
| 148 | Leishmaniasis_Homo sapiens_hsa05140 | 0.00513093 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00329996 |
| 150 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0335137 |
| 151 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0062725 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0053637 |
| 153 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | -0.0014516 |

